Brought to you by 
Baxter Healthcare licenses Angiotech's surgical sealants
14 Mar 2003
Executive Summary
Aiming to expand its position in the biosurgery market, Baxter Healthcare licensed from Angiotech Pharmaceuticals (biomaterials and drug-coated devices) worldwide marketing and distribution rights (excluding Japan and certain unspecified territories) to its CoSeal surgical sealant and Adhibit surgical anti-adhesive.
Deal Industry
- Biotechnology
- Medical Devices
-
Medical Devices
- Biomaterials
-
Surgical Equipment & Devices
- Surgical Sealants
Deal Status
- Final
Deal Type
-
Alliance
- Includes Royalty or Profit Split Information
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Baxter Healthcare licenses Angiotech's surgical sealants
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice